Avermectin derivatives
Abstract
A compound represented by the general formula (I) or a salt thereof: wherein, —X Y— represents —CH═CH—, —CH 2 —CH 2 — or the like, between R 1 and the carbon atom at 4′-position represents a single bond or a double bond, between R 2 and the carbon atom at 5-position represents a single bond or a double bond, and for example, 1) when —X Y— represents —CH═CH— or —CH 2 —CH 2 —, and between R 1 and the carbon atom at 4′-position represents a double bond, R 1 represents ═C(R 11 )(R 12 ) (wherein R 11 represents a lower alkyl group or the like and R 12 represents a hydrogen atom or the like) or the like, and R 2 represents a hydroxyl group or the like, or R 2 may be combined together with the carbon atom at 5-position to form a carbonyl group, and 2) when —X Y— represents —CH═CH— or —CH 2 —CH 2 —, and between R 1 and the carbon atom at 4′-position represents a single bond, R 1 represents —OCH(R 1a )(R 1b ) (wherein R 1a represents a lower alkyl or the like and R 1b represents a hydrogen atom or the like) or the like, and R 2 represents a hydroxyl group or the like.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound represented by the general formula (I) or a salt thereof:
wherein, —X Y— represents —CH═CH—, —CH 2 —C(═O)—, —CH 2 —CH 2 —, or —CH 2 —CH(R 13 S)— (wherein R 13 represents a hydroxyl group or a lower alkylcarbonyloxy group,
between R 1 and the carbon atom at 4′-position represents a single bond or a double bond,
between R 2 and the carbon atom at 5-position represents a single bond or a double bond, and
1) when —X Y— represents —CH═CH— or —CH 2 —CH 2 , and between R 1 and the carbon atom at 4′-position represents a double bond,
R 1 represents ═C(R 11 )(R 12 ) <wherein R 11 represents a substituted or unsubstituted lower alkyl group, a formyl group, a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), —CH═N—OR 2 (wherein R 3 represents a hydrogen atom or a lower alkyl group), a lower alkenylcarbonyl group, —CH═N—NH—CONH 2 , a cyano group, —COR 4 (wherein R 4 represents a hydroxyl group, a lower alkenyloxy group ,or —N(R 5 )(R 6 ) (wherein R 5 and R 6 are combined together with the adjacent nitrogen atom to form a nitrogen-containing heterocyclic group)), a vinyl group substituted with a lower alkenyloxycarbonyl group, —CO—S—CH 2 —CH 2 —NH CO—R x (wherein R x represents a lower alkyl group), or —CH═CH—COOH, and R 12 represents a hydrogen atom, provided that when R 11 represents a cyano group, R 12 represents a hydrogen atom or a lower alkyl group>, or is combined together with the carbon atom at 4′-position to form a carbonyl group, and
when between R 2 and the carbon atom at 5-position represents a single bond, R 2 represents a hydroxyl group, a lower alkoxyl group, or a lower alkenyloxycarbonyloxy group, and
when between R 2 and the carbon atom at 5-position represents a double bond, R 2 is combined together with the carbon atom at 5-position to form a carbonyl group or a hydroxime group (—C(═NOH)—);
2) when —X Y— represents —CH═CH— or —CH 2 —CH 2 —, and between R 1 and the carbon atom at 4′-position represents a single bond,
R 1 represents a hydroxyl group, —OCH(R 1a )(R 1b ) <wherein R 1a represents a substituted or unsubstituted lower alkyl group, a formyl group, a carboxyl group, a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), —CH═N—OR 7 (wherein R 7 represents a hydrogen atom or a lower alkyl group), a lower alkenyloxycarbonyl group, —CH═N—NH—CONH 2 , a cyano group, —COR 8 {(wherein R 8 represents an arylalkyloxy group (wherein the aryl group may contain one or more heteroatoms as ring-constituting atoms) or —N(R 9 )(R 10 ) (wherein R 9 and R 10 are combined together with the adjacent nitrogen atom to form a nitrogen-containing heterocyclic group)}, a vinyl group substituted with a lower alkenyloxycarbonyl group, —CO—S—CH 2 —CH 2 —NH—CO—R Y (wherein R Y represents a lower alkyl group), —CH═CH—COOH, or a substituted or unsubstituted aryl group, and R 1b represents a hydrogen atom, provided that when R 1a represents a carboxyl group or a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), R 1b may further represents a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), a carboxyl group, a cyano group, or an aryl group>, a carboxymethyl group, or a cyanomethyl group, and
when between R 2 and the carbon atom at 5-position represents a single bond, R 2 represents a hydroxyl group, a lower alkoxyl group, or a lower alkenyloxycarbonyloxy group, and
when between R 2 and the carbon atom at 5-position represents a double bond, R 2 is combined together with the carbon atom at 5-position to form a carbonyl group or a hydroxime group (—C(═NOH)—);
3) when —X Y— represents —CH 2 —C(═O)—, and between R 1 and the carbon atom at 4′-position represents a double bond,
R 1 represents ═C(R 11a )(R 12a ) (wherein R 11a represents a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group) or —COOCH 2 CH═CH 2 , and R 12a represents a hydrogen atom), or is combined together with the carbon atom at 4′-position to form carbonyl group,
between R 2 and the carbon atom at 5-position represents a single bond, and R 2 represents a hydroxyl group, a lower alkoxyl group, or a lower alkenyloxycarbonyloxy group;
4) when —X Y— represents —CH 2 —C(═O)—, and between R 1 and the carbon atom at 4′-position represents a single bond,
R 1 represents —OCH(R 1aa )(R 1ba ) <wherein R 1aa represents a substituted or unsubstituted lower alkyl group, a formyl group, a carboxyl group, a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), —CH═N—OR 7a (wherein R 7a represents a hydrogen atom or a lower alkyl group), a lower alkenyloxycarbonyl group, —CH═N—NH—CONH 2 , a cyano group, —COR 6a {wherein R 6a represents an arylalkyloxy group (wherein the aryl group may contain one or more heteroatoms as ring-constituting atoms), or —N(R 9a )(R 10a ) (wherein R 9a and R 10a are combined together with the adjacent nitrogen atom to form a nitrogen-containing heterocyclic group)}, a vinyl group substituted with a lower alkenyloxycarbonyl group, —CO—S—CH 2 —CH 2 —NH—CO—R Ya (wherein R Ya represents a lower alkyl group), —CH═CH—COOH, or a substituted or unsubstituted aryl group, and R 1ba represents a hydrogen atom, provided that when R 1aa represents a carboxyl group or a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), R 1ba may further represents a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), a carboxyl group, a cyano group, or an aryl group>, and
when between R 2 and the carbon atom at 5-position represents a single bond, R 2 represents a hydroxyl group, a lower alkoxyl group, or a lower alkenyloxycarbonyloxy group, and
when between R 2 and the carbon atom at 5-position represents a double bond, R 2 is combined together with the carbon atom at 5-position to form a carbonyl group or a hydroxime group (—C(═NOH)—);
5) when —X Y— represents —CH 2 —CH(R 13 )— (wherein R 18 has the same meaning as that defined above), and between R 1 and the carbon atom at 4′-position represents a double bond,
R 1 represents ═C(R 11b )(R 12b ) (wherein R 11b represents a cyano group, a carboxyl group, a lower alkoxycarbonyl group, or a lower alkenyloxycarbonyl group, or is combined togethrer with the carbon atom at 4′-position to form a carbonyl group, and R 12b represents a hydrogen atom),
between R 2 and the carbon atom at 5-position represents a single bond, and R 2 represents a hydroxyl group, a lower alkoxyl group, or a lower alkenyloxycarbonyloxy group; and
6) when —X Y— represents —CH 2 —CH(R 13 )— (wherein R 13 has the same meaning as that defined above), and between R 1 and the carbon atom at 4′-position represents a single bond,
R 1 represents —OCH(R 1ab )(R 1bb ) <wherein R 1ab represents a substituted or unsubstituted lower alkyl group, a formyl group, a carboxyl group, a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), —CH═N—OR 7b (wherein R 7b represents a hydrogen atom or a lower alkyl group), a lower alkenyloxycarbonyl group, —CH═N—NH—CONH 2 , a cyano group, —COR 8b }wherein R 8b represents an arylalkyloxy group (wherein the aryl group may contain one or more heteroatoms as ring-constituting atoms), or —N(R 9b )(R 10b ) (wherein R 9b and R 10b are combined together with the adjacent nitrogen atom to form a nitrogen-containing heterocyclic group)}, a vinyl group substituted with a low r alkenyloxycarbonyl group, —CO—S—CH 2 —CH 2 —NH—CO—R Yb (wherein R Yb represents a lower alkyl group), —CH═CH—COOH, or a substituted or unsubstituted aryl group, and R 1bb represents a hydrogen atom, provided that when R 1ab represents a carboxyl group or a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), R 1bb may further represents a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group), a carboxyl group, a cyano group, or an aryl group>, and
when between R 2 and the carbon atom at 5-position represents a single bond, R 2 represents a hydroxyl group, a lower alkoxyl group, or a lower alkenyloxycarbonyloxy group, and
when between R 2 and the carbon atom at 5-position represents a double bond, R 2 is combined together with the carbon atom at 6-position to form a carbonyl group or a hydroxime group (—C(═NOH)—)
2 . The compound or the salt according to claim 1 , wherein —X Y— is —CH═CH—.
3 . The compound or the salt according to claim 1 , wherein —X Y— is —CH 2 —CH 2 —.
4 . The compound or the salt according to any one of claims 1 to 3 , wherein R 11 is a substituted or unsubstituted lower alkyl group, a formyl group, a lower alkoxycarbonyl group, a lower alknenylcarbonyl group, a cyano group, or —COR 4 (wherein R 4 has the same meaning as that defined above).
5 . The compound or the salt according to any one of claims 1 to 3 , wherein R 1 is a hydroxyl group or —OCH 2 R 1ac {wherein R 1ac represents a substituted or unsubstituted lower alkyl group, a carboxyl group, or a lower alkoxycarbonyl group (wherein a lower alkyl moiety of said lower alkoxycarbonyl group may be substituted with a heterocyclic group)}.
6 . The compound or the salt according to any one of claims 1 to 5 , wherein R 2 is a hydroxyl group or a lower alkenyloxycarbonyloxy group.
7 . A medicament which comprises the compound according to any one of claims 1 to 6 or a physiologically acceptable salt thereof as an active ingredient.
8 . A method for therapeutic treatment of parasitosis which comprises the step of administering to a mammal including a human a therapeutically effective amount of the compound according to any one of claims 1 to 6 or a physiologically acceptable salt thereof.
9 . A medicament for therapeutic treatment of parasitosis which comprises the compound according to any one of claims 1 to 6 or a physiologically acceptable salt thereof as an active ingredient.
10 . Use of the compound according to any one of claims 1 to 6 or a physiologically acceptable salt thereof for manufacture of an antiparasitic agent.Join the waitlist — get patent alerts
Track US2004087519A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.